Ogoegbunam Agubuzu, MD
Physical Medicine and Rehabilitation · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Agubuzu’s office at (415) 600-1020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$55,158
Medicare paid this office $55,158 for 155 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 73 | $15,162 | $160 |
| Return visit (30+ min) | 82 | $14,640 | $112 |
| New patient visit (45+ min) | 32 | $4,800 | $150 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 20 | $2,711 | $97 |
| New patient visit (60+ min) | 15 | $2,424 | $162 |
See all 11 services
| Long return visit (40+ min) | 73 | $15,162 | $160 |
| Return visit (30+ min) | 82 | $14,640 | $112 |
| New patient visit (45+ min) | 32 | $4,800 | $150 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 20 | $2,711 | $97 |
| New patient visit (60+ min) | 15 | $2,424 | $162 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 17 | $2,197 | $105 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 16 | $1,624 | $81 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 17 | $1,229 | $59 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 18 | $1,072 | $43 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 17 | $198 | $10 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 18 | $112 | $5 |
Who their Medicare patients are
155 Original Medicare patients in 2024. Average age 75 · Women 57% · Health risk score 0.85. At or below the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 1.53.
Conditions among them: High blood pressure 67% · Coronary heart disease 21% · Depression 21% · Diabetes 19% · Cancer 17% · Chronic kidney disease 14% · Atrial fibrillation 14%.
The office billed $357,983, Medicare allowed $74,871 and paid $55,158; for 557 services of 30 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 155 | 557 | 75 | 0.85 | $357,983 | $55,158 |
| 2023 | 199 | 647 | 75 | 0.82 | $366,548 | $66,775 |
| 2022 | 245 | 972 | 75 | 0.84 | $483,943 | $93,306 |
| 2021 | 298 | 846 | 76 | 0.90 | $460,745 | $79,934 |
| 2020 | 221 | 693 | 76 | 0.99 | $354,423 | $69,537 |
| 2019 | 291 | 870 | 76 | 0.99 | $474,188 | $89,846 |
| 2018 | 116 | 246 | 77 | 0.86 | $128,952 | $29,428 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Long return visit (40+ min) | 103 | $23,379 | $158 |
| Return visit (30+ min) | 69 | $11,925 | $112 |
| New patient visit (60+ min) | 54 | $9,591 | $178 |
| New patient visit (45+ min) | 29 | $4,015 | $138 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 23 | $2,610 | $104 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 15 | $2,253 | $113 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 12 | $1,750 | $109 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 16 | $1,553 | $86 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 19 | $973 | $46 |
| Ultrasonic guidance for needle placement | 11 | $824 | $55 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 29 | $336 | $10 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 18 | $94 | $5 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $42 | None |
2022: 16 services
| Long return visit (40+ min) | 116 | $25,842 | $166 |
| Return visit (30+ min) | 133 | $23,716 | $115 |
| New patient visit (60+ min) | 53 | $10,408 | $196 |
| New patient visit (45+ min) | 51 | $6,407 | $126 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 27 | $3,147 | $105 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 26 | $3,130 | $101 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 18 | $2,355 | $102 |
| Ultrasonic guidance for needle placement | 26 | $1,879 | $54 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 20 | $1,569 | $71 |
| Short return visit (20+ min) | 11 | $1,143 | $88 |
| Injection of substance into lower spine canal using imaging guidance | 11 | $1,077 | $90 |
| Injection of trigger points, 1-2 muscles | 18 | $1,039 | $47 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 16 | $1,028 | $54 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 20 | $1,019 | $46 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 50 | $689 | $11 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 28 | $105 | None |
2021: 16 services
| Return visit (30+ min) | 117 | $19,612 | $117 |
| New patient visit (45+ min) | 105 | $15,344 | $146 |
| Long return visit (40+ min) | 80 | $12,372 | $147 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 40 | $4,763 | $111 |
| New patient visit (60+ min) | 21 | $4,132 | $197 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 22 | $2,839 | $98 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 13 | $2,137 | $102 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 19 | $1,441 | $58 |
| Ultrasonic guidance for needle placement | 20 | $1,416 | $57 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 12 | $1,375 | $106 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 17 | $1,179 | $59 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 22 | $1,098 | $46 |
| Injection of trigger points, 1-2 muscles | 12 | $916 | $54 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 12 | $794 | $61 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 53 | $667 | $11 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 18 | $77 | None |
2020: 14 services
| Long return visit (40+ min) | 94 | $17,296 | $133 |
| New patient visit (60+ min) | 63 | $11,107 | $176 |
| Return visit (30+ min) | 69 | $9,624 | $102 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 31 | $4,534 | $94 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 22 | $4,398 | $191 |
| Ultrasonic guidance for needle placement | 37 | $3,002 | $54 |
| New patient visit (45+ min) | 22 | $2,961 | $135 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 14 | $2,185 | $121 |
| Injection of trigger points, 1-2 muscles | 26 | $1,833 | $50 |
| Short return visit (20+ min) | 17 | $1,317 | $73 |
| Injection of trigger points, 3 or more muscles | 14 | $1,250 | $62 |
| Injection of substance into lower spine canal using imaging guidance | 12 | $1,135 | $87 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 12 | $679 | $57 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 23 | $296 | $11 |
2019: 16 services
| Long return visit (40+ min) | 144 | $32,038 | $128 |
| New patient visit (60+ min) | 109 | $19,753 | $181 |
| Return visit (30+ min) | 34 | $4,423 | $103 |
| New patient visit (45+ min) | 25 | $3,815 | $153 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 32 | $3,603 | $100 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 30 | $3,406 | $90 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 17 | $2,797 | $165 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 19 | $2,214 | $101 |
| Ultrasonic guidance for needle placement | 30 | $1,861 | $50 |
| Injection of trigger points, 1-2 muscles | 24 | $1,372 | $51 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 11 | $1,361 | $91 |
| Injection of substance into lower spine canal using imaging guidance | 15 | $1,352 | $80 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 19 | $1,286 | $58 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 19 | $997 | $43 |
| Injection of trigger points, 3 or more muscles | 12 | $889 | $56 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 49 | $589 | $11 |
2018: 4 services
| Long return visit (40+ min) | 53 | $9,689 | $136 |
| New patient visit (60+ min) | 37 | $7,082 | $191 |
| New patient visit (45+ min) | 42 | $6,376 | $152 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 19 | $220 | $11 |
Drugs they prescribed that Part D paid
$1,254
Pharmacies billed $1,254 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 122) in 2024. At or below the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 12%.
122 generic and 0 brand-name prescriptions · $1,254 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gabapentin | 71 | $791 | $11 |
| Meloxicam | 29 | $65 | $2 |
Year by year
| 2024 | 122 | 41 | 0% (0) | 0% | $1,254 |
| 2023 | 207 | 58 | 0% (0) | 0% | $3,142 |
| 2022 | 190 | 50 | 0% (0) | 0% | $3,426 |
| 2021 | 225 | 76 | None | None | $4,953 |
| 2020 | 247 | 65 | 10% (24) | None | $7,772 |
| 2019 | 401 | 122 | 24% (95) | 7% | $11,197 |
| 2018 | 210 | 94 | 9% (18) | 6% | $4,667 |
| 2017 | 22 | None | 0% (0) | 0% | $683 |
| 2016 | 15 | None | 0% (0) | None | $1,403 |
| 2015 | 55 | None | 0% (0) | None | $19,385 |
| 2014 | 79 | 13 | 0% (0) | 23% | $6,167 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Gabapentin | 125 | $1,837 | $15 |
| Baclofen | 17 | $283 | $17 |
| Meloxicam | 31 | $78 | $3 |
2022: 5 drugs
| Gabapentin | 89 | $1,572 | $18 |
| Baclofen | 20 | $496 | $25 |
| Cyclobenzaprine | 12 | $346 | $29 |
| Methylprednisolone | 17 | $173 | $10 |
| Meloxicam | 35 | $145 | $4 |
2021: 4 drugs
| Gabapentin | 105 | $1,828 | $17 |
| Baclofen | 39 | $1,096 | $28 |
| Methylprednisolone | 18 | $147 | $8 |
| Meloxicam | 32 | $109 | $3 |
2020: 6 drugs
| Gabapentin | 91 | $1,622 | $18 |
| Diclofenac | 14 | $829 | $59 |
| Baclofen | 32 | $510 | $16 |
| Amitriptyline | 17 | $359 | $21 |
| Methylprednisolone | 15 | $146 | $10 |
| Meloxicam | 30 | $131 | $4 |
2019: 11 drugs
| Gabapentin | 123 | $2,234 | $18 |
| Hydrocodone-Acetaminophen | 50 | $1,413 | $28 |
| Morphine Sulfate | 13 | $710 | $55 |
| Diclofenac | 14 | $694 | $50 |
| Baclofen | 42 | $673 | $16 |
| Celecoxib | 12 | $482 | $40 |
| Methylprednisolone | 20 | $256 | $13 |
| Amitriptyline | 21 | $242 | $12 |
| Meloxicam | 30 | $161 | $5 |
| Oxycodone | 12 | $147 | $12 |
| Cyclobenzaprine | 14 | $116 | $8 |
2018: 6 drugs
| Gabapentin | 67 | $1,091 | $16 |
| Duloxetine | 16 | $689 | $43 |
| Diclofenac | 15 | $535 | $36 |
| Baclofen | 36 | $461 | $13 |
| Hydrocodone-Acetaminophen | 11 | $220 | $20 |
| Meloxicam | 26 | $99 | $4 |
Money from drug and device companies
$66 in 2021
| 2021 | 1 | 1 | None | $66 |
| 2020 | 1 | 2 | None | $39 |
| 2019 | 1 | 24 | None | $207 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Si-Bone | Ifuse Implant | $66 | 1 payment
|
See the published payment
| Si-Bone | Meals · 2021-08-18 | Ifuse Implant | $66 |
See earlier years (2020, 2019)
2020: $39
| Pfizer | Lyrica | $39 | 2 payments
|
2019: $207
| Pfizer | Lyrica | $207 | 24 payments
|
Professional record
- NPI
- 1598102519
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Student in a training program (390200000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2013-05-31
- NPI last updated
- 2020-06-03
- NPI record certified
- 2020-06-03
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 155 N Fresno St, Fresno, CA, 93701